Mizuho Financial Group, Inc. (NYSE:MFG – Get Free Report) shares traded down 2.2% during trading on Tuesday . The company traded as low as $4.05 and last traded at $4.07. 1,745,104 shares were traded during trading, an increase of 76% from the average session volume of 993,525 shares. The stock had previously closed at $4.16.
Mizuho Financial Group Price Performance
The company has a market cap of $52.46 billion, a price-to-earnings ratio of 13.70, a price-to-earnings-growth ratio of 0.76 and a beta of 0.39. The company has a current ratio of 0.96, a quick ratio of 0.96 and a debt-to-equity ratio of 1.22. The company has a fifty day moving average price of $4.16 and a two-hundred day moving average price of $4.07.
Mizuho Financial Group (NYSE:MFG – Get Free Report) last issued its earnings results on Wednesday, July 31st. The bank reported $0.13 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.02. The business had revenue of $15.27 billion for the quarter. Mizuho Financial Group had a net margin of 6.38% and a return on equity of 6.64%. As a group, equities research analysts anticipate that Mizuho Financial Group, Inc. will post 0.39 EPS for the current fiscal year.
Hedge Funds Weigh In On Mizuho Financial Group
About Mizuho Financial Group
Mizuho Financial Group, Inc, together with its subsidiaries, engages in banking, trust, securities, and other businesses related to financial services in Japan, the Americas, Europe, Asia/Oceania, and internationally. It operates through Retail & Business Banking Company, Corporate & Institutional Company, Global Corporate Company, Global Markets Company, Asset Management Company, and Others segments.
See Also
- Five stocks we like better than Mizuho Financial Group
- Upcoming IPO Stock Lockup Period, Explained
- Biohaven Stock Soars on Drug Trial Results: Time to Jump In?
- How to Calculate Stock Profit
- Is AMD a Legitimate Threat to NVIDIA? What Investors Should Watch
- Transportation Stocks Investing
- Novo Nordisk’s Setback Won’t Last: A Game-Changing Drug Emerges
Receive News & Ratings for Mizuho Financial Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mizuho Financial Group and related companies with MarketBeat.com's FREE daily email newsletter.